|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 277/56 | |
| A61K 31/426 | |||
| A61P 19/06 |
| (11) | Patento numeris | 2398784 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 10724664.7 |
| Europos patento paraiškos padavimo data | 2010-06-10 | |
| (97) | Europos patento paraiškos paskelbimo data | 2011-12-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-10-17 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2010/038143 |
| Data | 2010-06-10 |
| (87) | Numeris | WO 2010/144685 |
| Data | 2010-12-16 |
| (30) | Numeris | Data | Šalis |
| 185775 P | 2009-06-10 | US | |
| 222583 P | 2009-07-02 | US | |
| 233552 P | 2009-08-13 | US | |
| 235481 P | 2009-08-20 | US |
| (72) |
PIRAN, Maytal, IL
METSGER, Leonid, IL
|
| (73) |
Teva Pharmaceutical Industries Ltd. ,
124 Dvora HaNevi'a St., Tel Aviv 6944020,
IL
|
| (54) | CRYSTALLINE FORMS OF FEBUXOSTAT |
| CRYSTALLINE FORMS OF FEBUXOSTAT |